Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics

已完结 20 由 xiaoshen 发布于 2025/10/13 16:43:48

DOI:10.1038/s41573-024-01051-x
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1038/s41573-024-01051-x

其它数据库

Abstract：Remarkable progress has been made in recent decades in engineering antibodies and other protein therapeutics, including enhancements to existing functions as well as the advent of novel mole

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierEfficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial